Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

ABSTRACT: Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

PROVIDER: PRJNA488470 | ENA |

REPOSITORIES: ENA